Shu, C.-C.; Pan, S.-W.; Feng, J.-Y.; Wang, J.-Y.; Chan, Y.-J.; Yu, C.-J.; Su, W.-J.
The Clinical Significance of Programmed Death-1, Regulatory T Cells and Myeloid Derived Suppressor Cells in Patients with Nontuberculous Mycobacteria-Lung Disease. J. Clin. Med. 2019, 8, 736.
https://doi.org/10.3390/jcm8050736
AMA Style
Shu C-C, Pan S-W, Feng J-Y, Wang J-Y, Chan Y-J, Yu C-J, Su W-J.
The Clinical Significance of Programmed Death-1, Regulatory T Cells and Myeloid Derived Suppressor Cells in Patients with Nontuberculous Mycobacteria-Lung Disease. Journal of Clinical Medicine. 2019; 8(5):736.
https://doi.org/10.3390/jcm8050736
Chicago/Turabian Style
Shu, Chin-Chung, Sheng-Wei Pan, Jia-Yih Feng, Jann-Yuan Wang, Yu-Jiun Chan, Chong-Jen Yu, and Wei-Juin Su.
2019. "The Clinical Significance of Programmed Death-1, Regulatory T Cells and Myeloid Derived Suppressor Cells in Patients with Nontuberculous Mycobacteria-Lung Disease" Journal of Clinical Medicine 8, no. 5: 736.
https://doi.org/10.3390/jcm8050736
APA Style
Shu, C.-C., Pan, S.-W., Feng, J.-Y., Wang, J.-Y., Chan, Y.-J., Yu, C.-J., & Su, W.-J.
(2019). The Clinical Significance of Programmed Death-1, Regulatory T Cells and Myeloid Derived Suppressor Cells in Patients with Nontuberculous Mycobacteria-Lung Disease. Journal of Clinical Medicine, 8(5), 736.
https://doi.org/10.3390/jcm8050736